Kenneth C Jackson

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. ncbi request reprint Pharmacotherapy for neuropathic pain
    Kenneth C Jackson
    Pharmacotherapy Outcomes Research Center, Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, Utah 84108, USA
    Pain Pract 6:27-33. 2006
  2. ncbi request reprint Pharmacotherapy in lower back pain
    Kenneth C Jackson
    Pain and Palliative Care, University Hospital and College of Pharmacy, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
    Drugs Today (Barc) 40:765-72. 2004
  3. ncbi request reprint Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations
    Diana I Brixner
    University of Utah College of Pharmacy, Salt Lake City, UT 84112, USA
    Curr Med Res Opin 24:2597-607. 2008
  4. ncbi request reprint Economic evaluations in pain management: principles and methods
    Carl V Asche
    Pharmacotherapy Outcomes Research Center, Department of Pharmacotherapy, University of Utah College of Pharmacy, 421 Wakara Way, Suite 208, Salt Lake City, UT 84108, USA
    J Pain Palliat Care Pharmacother 20:15-23. 2006
  5. ncbi request reprint Persistent pain management for improved quality of life
    Kenneth C Jackson
    Texas Tech University Health Sciences Center, Lubbock
    J Am Pharm Assoc (2003) 43:S30-1. 2003
  6. ncbi request reprint Clinician beliefs about opioid use and barriers in chronic nonmalignant pain
    Paula H Grahmann
    Texas Tech University School of Pharmacy, International Pain Center, Texas Tech Medical Center, 2319 81st Street, Lubbock, TX 79423, USA
    J Pain Palliat Care Pharmacother 18:7-28. 2004
  7. ncbi request reprint Anticipating and treating opioid-associated adverse effects
    Christopher M Herndon
    Ortho McNeil, Division of Clinical Affairs, O Fallon, IL 62269, USA
    Expert Opin Drug Saf 2:305-19. 2003
  8. ncbi request reprint Role of corticosteroids in palliative care
    Allen Shih
    Good Samaritan Hospital, 407 14th Ave SE, Payallup, WA, USA
    J Pain Palliat Care Pharmacother 21:69-76. 2007
  9. doi request reprint Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database
    Kenneth C Jackson
    Clin Ther 30:1558-63. 2008
  10. ncbi request reprint Management of opioid-induced gastrointestinal effects in patients receiving palliative care
    Christopher M Herndon
    School of Pharmacy, Texas Tech University Health Sciences Center, Lubbock, USA
    Pharmacotherapy 22:240-50. 2002

Collaborators

Detail Information

Publications10

  1. ncbi request reprint Pharmacotherapy for neuropathic pain
    Kenneth C Jackson
    Pharmacotherapy Outcomes Research Center, Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, Utah 84108, USA
    Pain Pract 6:27-33. 2006
    ..In refractory patients, combination therapy using two agents with synergistic mechanisms of action may offer greater pain relief without compromising the side-effect profile of each agent...
  2. ncbi request reprint Pharmacotherapy in lower back pain
    Kenneth C Jackson
    Pain and Palliative Care, University Hospital and College of Pharmacy, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
    Drugs Today (Barc) 40:765-72. 2004
    ..More critical research is needed to further define the roles of these medications in treating pain associated with lower back injury...
  3. ncbi request reprint Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations
    Diana I Brixner
    University of Utah College of Pharmacy, Salt Lake City, UT 84112, USA
    Curr Med Res Opin 24:2597-607. 2008
    ....
  4. ncbi request reprint Economic evaluations in pain management: principles and methods
    Carl V Asche
    Pharmacotherapy Outcomes Research Center, Department of Pharmacotherapy, University of Utah College of Pharmacy, 421 Wakara Way, Suite 208, Salt Lake City, UT 84108, USA
    J Pain Palliat Care Pharmacother 20:15-23. 2006
    ....
  5. ncbi request reprint Persistent pain management for improved quality of life
    Kenneth C Jackson
    Texas Tech University Health Sciences Center, Lubbock
    J Am Pharm Assoc (2003) 43:S30-1. 2003
    ..To provide better care for patients with persistent pain, health care providers should educate themselves about the distinctions among addiction, physical dependence, pseudoaddiction, tolerance, and pseudotolerance...
  6. ncbi request reprint Clinician beliefs about opioid use and barriers in chronic nonmalignant pain
    Paula H Grahmann
    Texas Tech University School of Pharmacy, International Pain Center, Texas Tech Medical Center, 2319 81st Street, Lubbock, TX 79423, USA
    J Pain Palliat Care Pharmacother 18:7-28. 2004
    ..Opioids were most consistently accepted for sickle cell disease pain and least commonly endorsed for headaches, myofascial pain, and fibromyalgia. Factors that may influence clinicians' perceptions about opioids are discussed...
  7. ncbi request reprint Anticipating and treating opioid-associated adverse effects
    Christopher M Herndon
    Ortho McNeil, Division of Clinical Affairs, O Fallon, IL 62269, USA
    Expert Opin Drug Saf 2:305-19. 2003
    ..These adverse events, ranging from nuisance to therapy-limiting, are manageable when addressed quickly and appropriately. Opioids are safe and efficacious analgesics when these effects are considered...
  8. ncbi request reprint Role of corticosteroids in palliative care
    Allen Shih
    Good Samaritan Hospital, 407 14th Ave SE, Payallup, WA, USA
    J Pain Palliat Care Pharmacother 21:69-76. 2007
    ..In the setting of palliative care, glucocorticoids have many uses, including many symptoms of malignancy, nausea, vomiting, depression, fatigue, anorexia and cachexia...
  9. doi request reprint Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database
    Kenneth C Jackson
    Clin Ther 30:1558-63. 2008
    ..The aim of this analysis was to assess the impact of multiple combination therapies on medication possession ratios (MPRs) in an antihypertensive naive population...
  10. ncbi request reprint Management of opioid-induced gastrointestinal effects in patients receiving palliative care
    Christopher M Herndon
    School of Pharmacy, Texas Tech University Health Sciences Center, Lubbock, USA
    Pharmacotherapy 22:240-50. 2002
    ..Common agents administered for nausea are butyrophenones, phenothiazines, metoclopramide, and serotonin-receptor antagonists. Those given to manage constipation are stimulant laxatives and stool softeners, individually or in combination...